- Meeting abstract
- Open Access
Seroprevalence of HTLV infection in Spain among immigrant pregnant women
© Treviño et al; licensee BioMed Central Ltd. 2011
Published: 6 June 2011
The overall seroprevalence of HTLV infection among pregnant women in Spain is below 0.02% and therefore universal screening is not recommended. However, given that a large proportion of immigrant pregnant women come from HTLV-1 endemic regions, this population might warrant specific screening considerations.
From January 2009 to December 2010, a cross-sectional study was carried out among immigrant pregnant women attended at 14 different Spanish hospitals. An enzyme immunoassay (EIA) was used for testing serum HTLV-1/2 antibodies, being reactive samples further confirmed by Western blot.
A total of 3,337 pregnant women were examined. The origin was as follows: Latin America 1579 (47%), East Europe 606 (18%), North Africa 507 (16%), Sub-Saharan Africa 316 (9%), Western Europe 116 (5%), and Asia 163 (5%). A total of 7 samples were confirmed as HTLV positive, 6 HTLV-1 and 1 HTLV-2. HTLV-1 was found in 5 women coming from Latin America and 1 from Morocco. The only single HTLV-2 woman came from Ghana.
The overall HTLV seroprevalence in immigrant pregnant women was 0.2%, being 0.3% among Latin Americans and 0.2% among Africans. It was absent among women coming from other regions.
The seroprevalence of HTLV infection among immigrant pregnant women in Spain is 0.2%, being all cases found among women from Latin America and Africa. Given the benefit of preventing vertical transmission of HTLV, antenatal HTLV screening could be advisable in pregnant women coming from these regions.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.